The U.S. Securities and Exchange Commission agreed to dismiss its civil suit against former Mylan executive Ramkumar V. Rayapureddy, in what his Linklaters counsel are deeming as a “second victory” after the government also dismissed parallel criminal charges earlier this year just shy of a trial.
In a stipulated dismissal Tuesday, the SEC agreed that it would dismiss the civil action against the pharmaceutical chief information officer with prejudice, with each party bearing its own fees and costs.
